Skip to content

PHARMA FUTUR: what changed

BE 0787.394.827NACE 82.990, Other business support servicesOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
-€269,752
2024 · €26,930-€296,682
Equity
-€244,402
2024 · €25,350-€269,752
Cash
€395
2024 · €6,733-€6,338
Balance sheet total
€629,295
2024 · €790,586-€161,291

Largest movements

2024 to 2025
Assets
  • Receivables within one year -€117,428

    down €117,428 (-86.4%), from €135,879 to €18,451

    of which Trade receivables: -€69,415

  • Intangible fixed assets -€32,500

    down €32,500 (-10.1%), from €321,093 to €288,593

  • Stocks and contracts -€17,250

    down €17,250 (-9.3%), from €185,064 to €167,814

Equity and liabilities
  • Profit (loss) carried forward -€244,402

    new in 2025: -€244,402

  • Other debts -€236,240

    down €236,240 (-83.4%), from €283,259 to €47,019

  • Debts after one year +€227,774

    up €227,774 (+82.8%), from €275,000 to €502,774

    of which Financial debts: +€227,774

  • Tax, wage and social debts +€43,136

    up €43,136 (+142%), from €30,343 to €73,479

    of which Remuneration and social security: +€24,943

  • Current portion of long-term debt +€38,363

    up €38,363 (+2,491%), from €1,540 to €39,903

Income statement
  • Staff costs +€149,173

    up €149,173 (+510%), from €29,247 to €178,420

  • Gross operating margin -€63,775

    down €63,775 (-61.6%), from €103,582 to €39,807

  • Depreciation +€43,920

    up €43,920 (+572%), from €7,677 to €51,597

  • Write-downs -€34,517

    down €34,517, from €17,259 to -€17,259

  • Other operating charges +€25,715

    up €25,715 (+418%), from €6,158 to €31,874

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €26,930
Gross operating margin -€63,775
Staff costs -€149,173
Depreciation -€43,920
Write-downs +€34,517
Other operating charges -€25,715
Other operating items -€40,064
Financial income -€707
Financial charges -€17,062
Taxes +€9,217
Result 2025 -€269,752
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations -€285,824
Investment -€24,817
Financing +€304,304
Cash 2024 €6,733
Net result for the year -€269,752
Depreciation +€51,597
Stocks and contracts +€17,250
Receivables within one year +€117,428
Deferred charges and accrued income -€6,504
Trade debts -€4,573
Tax, wage and social debts +€43,136
Other debts -€236,240
Accrued charges and deferred income +€1,835
Investment in fixed assets (net) -€24,817
Debts after one year +€227,774
Current portion of long-term debt +€38,363
Short-term financial debts +€38,166
Cash 2025 €395
brings cash intakes cash out
Every line side by side 52 lines
Line Code 2024 2025 Change %
Total assets 20/58 €790,586 €629,295 -€161,291 -20.4%
Fixed assets 21/28 €458,947 €432,167 -€26,780 -5.8%
Intangible fixed assets 21 €321,093 €288,593 -€32,500 -10.1%
Tangible fixed assets 22/27 €137,854 €143,574 +€5,720 +4.1%
Plant, machinery and equipment 23 - €1,269 +€1,269
Furniture and vehicles 24 €52,866 €40,908 -€11,958 -22.6%
Leasing and similar rights 25 €4,500 €3,589 -€911 -20.2%
Other tangible fixed assets 26 €80,488 €97,808 +€17,320 +21.5%
Current assets 29/58 €331,639 €197,128 -€134,511 -40.6%
Stocks and contracts in progress 3 €185,064 €167,814 -€17,250 -9.3%
Stocks 30/36 €185,064 €167,814 -€17,250 -9.3%
Amounts receivable within one year 40/41 €135,879 €18,451 -€117,428 -86.4%
Trade receivables 40 €87,867 €18,451 -€69,415 -79.0%
Other amounts receivable 41 €48,012 - -€48,012
Cash at bank and in hand 54/58 €6,733 €395 -€6,338 -94.1%
Deferred charges and accrued income 490/1 €3,963 €10,467 +€6,504 +164%
Total equity and liabilities 10/49 €790,586 €629,295 -€161,291 -20.4%
Equity 10/15 €25,350 -€244,402 -€269,752
Reserves 13 €25,350 - -€25,350
Distributable reserves 133 €25,350 - -€25,350
Profit (loss) carried forward 14 - -€244,402 -€244,402
Amounts payable 17/49 €765,236 €873,696 +€108,461 +14.2%
Amounts payable after more than one year 17 €275,000 €502,774 +€227,774 +82.8%
Financial debts 170/4 - €227,774 +€227,774
Other amounts payable 178/9 €275,000 €275,000 = 0.0%
Amounts payable within one year 42/48 €489,866 €368,718 -€121,148 -24.7%
Current portion of amounts payable after more than one year 42 €1,540 €39,903 +€38,363 +2,491%
Financial debts 43 €23,837 €62,003 +€38,166 +160%
Credit institutions 430/8 €23,837 €62,003 +€38,166 +160%
Trade debts 44 €150,887 €146,314 -€4,573 -3.0%
Suppliers 440/4 €150,887 €146,314 -€4,573 -3.0%
Taxes, remuneration and social security 45 €30,343 €73,479 +€43,136 +142%
Taxes 450/3 €8,963 €27,156 +€18,193 +203%
Remuneration and social security 454/9 €21,380 €46,323 +€24,943 +117%
Other amounts payable 47/48 €283,259 €47,019 -€236,240 -83.4%
Accrued charges and deferred income 492/3 €370 €2,205 +€1,835 +496%
Non-recurring operating income 76A €52,565 - -€52,565
Remuneration, social security and pensions 62 €29,247 €178,420 +€149,173 +510%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €7,677 €51,597 +€43,920 +572%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 €17,259 -€17,259 -€34,517
Other operating charges 640/8 €6,158 €31,874 +€25,715 +418%
Non-recurring operating charges 66A - €40,064 +€40,064
Gross operating margin 9900 €103,582 €39,807 -€63,775 -61.6%
Operating profit (loss) 9901 €43,241 -€244,890 -€288,130
Financial income 75/76B €1,545 €839 -€707 -45.7%
Recurring financial income 75 €1,545 €839 -€707 -45.7%
Financial charges 65/66B €8,434 €25,497 +€17,062 +202%
Recurring financial charges 65 €8,434 €25,497 +€17,062 +202%
Profit (loss) for the period before taxes 9903 €36,352 -€269,548 -€305,899
Income taxes 67/77 €9,422 €204 -€9,217 -97.8%
Profit (loss) for the period 9904 €26,930 -€269,752 -€296,682
Profit (loss) for the period to be appropriated 9905 €26,930 -€269,752 -€296,682

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

The filed figures and these assumptions give no positive value. The adjusted equity and the average result are both zero or negative.

Part of the calculation comes out below zero. A shareholding is never worth less than zero, so the floor is zero.

Adjusted equity -€532,995

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
-€244,402
Intangible fixed assets (21)
-€288,593
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
-€532,995

Capitalised earnings

net result for the year (9904)
2025
-€269,752
excluding non-recurring income and charges
-€229,687
2024
€26,930
excluding non-recurring income and charges
-€25,635
2023
-€24,031
2022
€22,451
Average result, excluding non-recurring income and charges
-€93,118
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
not meaningful, as the average result is zero or negative

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 9 November 2026 via checked.be.